三博脑科公告，持股5%以上股东TBP 3Doctors (HK) Limited计划在本公告披露之日起十五个交易日后的 三个月内以集中竞价和大宗交易方式减持本公司股份不超过6089694股（占剔除公司回购专用账户股份 数量后总股本的3.00%）。其中，通过集中竟价方式减持不超过2029898股（占剔除公司回购专用账户 股份数量后总股本的1.00%），通过大宗交易方式减持不超过4059796股（占剔除公司回购专用账户股 份数量后总股本的2.00%）。 (本文来自第一财经) ...

三博脑科（SZ 301293，收盘价：63.72元）8月20日晚间发布公告称，持有三博脑科医院管理集团股份 有限公司股份约3121万股（占剔除公司回购专用账户股份数量后总股本的15.37%）的持股5%以上股东 TBP 3Doctors (HK) Limited（简称"TBP"）计划在本公告披露之日起十五个交易日后的三个月内以集中 竞价和大宗交易方式减持公司股份不超过约609万股（占剔除公司回购专用账户股份数量后总股本的 3%）。其中，通过集中竟价方式减持不超过约203万股（占剔除公司回购专用账户股份数量后总股本的 1%），通过大宗交易方式减持不超过约406万股（占剔除公司回购专用账户股份数量后总股本的 2%）。 2024年1至12月份，三博脑科的营业收入构成为：医疗占比99.67%，供应链占比0.33%。 （文章来源：每日经济新闻） ...

证券代码：301293 证券简称：三博脑科 公告编号：2025-028 三博脑科医院管理集团股份有限公司 关于持股 5%以上股东减持股份的预披露公告 公司股东 TBP 3Doctors (HK) Limited 保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有三博脑科医院管理集团股份有限公司（以下简称"公司"）股份 31,205,425 股（占剔除公司回购专用账户股份数量后总股本的 15.37%）的持股 5%以上股东 TBP 3Doctors (HK) Limited（以下简称"TBP"）计划在本公告披露之日起十五个 交易日后的三个月内以集中竞价和大宗交易方式减持本公司股份不超过 6,089,694 股（占剔除公司回购专用账户股份数量后总股本的 3.00%）。其中，通 过集中竟价方式减持不超过 2,029,898 股（占剔除公司回购专用账户股份数量后 总股本的 1.00%），通过大宗交易方式减持不超过 4,059,796 股（占剔除公司回 购专用账户股份数量后总股本的 2.00%）。 一、股 ...

Group 1 - The core viewpoint of the article highlights that Sanbo Brain Science's stock closed at 63.72 yuan, down 3.69%, with a rolling PE ratio of 119.43 times and a total market capitalization of 13.125 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical services sector is 49.21 times, with a median of 65.65 times, placing Sanbo Brain Science at the 39th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Sanbo Brain Science increased to 37,673, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Sanbo Brain Science Hospital Management Group Co., Ltd. primarily engages in clinical medical services, with its main products including medical services, pharmaceuticals, supply chain, and other businesses [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 393 million yuan, representing a year-on-year increase of 16.78%, and a net profit of 38.3136 million yuan, up 14.56%, with a gross profit margin of 26.44% [1]

Group 1 - The stock price of Sanbo Brain Science closed at 66.16 yuan on August 19, 2025, down 1.02% from the previous trading day, with a trading volume of 1.576 billion yuan [1] - The stock experienced significant volatility, with a fluctuation range of 6.18% after a quick rebound in the morning followed by a pullback [1] - Sanbo Brain Science operates in the medical services sector, focusing on brain-related medical fields, including diagnosis, treatment, and rehabilitation services, aiming to provide precise medical solutions [1] Group 2 - On August 19, 2025, the net outflow of main funds for Sanbo Brain Science was 45.8035 million yuan, with a cumulative net outflow of 333 million yuan over the past five days, indicating a short-term trend of capital outflow [1]

最新一期业绩显示，2025年一季报，公司实现营业收入3.93亿元，同比16.78%；净利润3831.36万元， 同比14.56%，销售毛利率26.44%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13三博脑科124.01129.755.83136.28亿行业平均 49.8161.684.29199.85亿行业中值65.6068.573.3572.44亿1药明康德19.3528.204.452664.63亿2康龙化成 28.5429.743.80533.28亿3爱尔眼科32.9134.305.591219.76亿4普蕊斯34.0729.172.6331.05亿5诺禾致源 34.2934.432.6467.76亿6华康洁净37.0453.372.0635.66亿7凯莱英37.9539.732.19377.04亿8诺思格 37.9938.812.9254.41亿9通策医疗40.0040.864.87204.90亿10华厦眼科41.0740.472.94173.46亿11万邦医药 45.8436.282.0731.03亿12昭衍新药62.27325.692.98241.26亿 来源：金融界 从行业市盈率 ...

Group 1 - The stock price of Sanbo Brain Science as of August 15, 2025, is 66.46 yuan, down by 1.36 yuan from the previous trading day [1] - The opening price for the day was 67.48 yuan, with a high of 69.80 yuan and a low of 65.71 yuan, resulting in a trading volume of 332,500 hands and a transaction amount of 2.232 billion yuan [1] - The company specializes in neurosurgery medical services, including precision medicine, with a total market capitalization of 13.69 billion yuan and a circulating market capitalization of 10.696 billion yuan [1] Group 2 - On August 15, the net outflow of main funds was 211 million yuan, with a cumulative net outflow of 181 million yuan over the past five days [1] - During the morning trading session, the stock experienced rapid fluctuations, with a quick drop of over 2% at 9:36 AM and a rebound of over 2% at 9:52 AM [1]

Group 1 - The core viewpoint of the article highlights that Sanbo Brain Science's stock closed at 66.46 yuan, down 2.01%, with a rolling PE ratio of 124.57 times and a total market value of 13.69 billion yuan [1] - The average PE ratio for the medical services industry is 49.76 times, with a median of 64.18 times, placing Sanbo Brain Science at the 39th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Sanbo Brain Science increased to 37,673, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Sanbo Brain Science Hospital Management Group Co., Ltd. primarily engages in clinical medical services, with main products including medical services, pharmaceuticals, supply chain, and other businesses [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 393 million yuan, a year-on-year increase of 16.78%, and a net profit of 38.31 million yuan, up 14.56%, with a gross profit margin of 26.44% [1]

脑机接口概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 002195 | 岩山科 技 | 3.55 | 12.85 | 37957.04 | 8.75 | | 600775 | 南京熊 猫 | 10.01 | 19.70 | 21253.20 | 12.81 | | 002173 | 创新医 疗 | 10.02 | 25.73 | 12956.12 | 4.97 | | 002465 | 海格通 信 | 0.15 | 6.22 | 12215.09 | 5.72 | | 301293 | 三博脑 科 | 8.51 | 24.66 | 8259.88 | 3.15 | | 300678 | 中科信 息 | 1.24 | 8.74 | 8140.51 | 8.39 | 截至8月14日收盘，脑机接口概念上涨0.92%，位居概念板块涨幅第3，板块内，18股上涨，博拓生物 20%涨停，创新医疗、南京熊猫等涨停，三博 ...

Group 1 - The core viewpoint of the news is that the brain-computer interface concept stocks in the A-share market have shown strong performance, with several companies experiencing significant price increases [1] Group 2 - Company performance highlights include: - Innovation Medical (002173) saw a price increase of 10.00%, with a total market capitalization of 9.995 billion and a year-to-date increase of 184.55% [2] - Pulite (002324) increased by 7.51%, with a market cap of 15.9 billion and a year-to-date increase of 50.88% [2] - Chengyitong (300430) rose by 6.65%, with a market cap of 6.657 billion and a year-to-date increase of 59.67% [2] - Saily Medical (603716) increased by 5.45%, with a market cap of 5.878 billion and a year-to-date increase of 326.18% [2] - Sanbo Brain Science (301293) rose by 3.79%, with a market cap of 12.9 billion and a year-to-date increase of 44.76% [2] - The MACD golden cross signal formation indicates a positive trend for these stocks [1]